2019•Pediatric DermatologyRequires access
Use of secukinumab in a pediatric patient leads to significant improvement in nail psoriasis and psoriatic arthritis
Leah Wells, Tyler S. Evans, Rachael Hilton, Lara Wine Lee, Natasha M. Ruth
Open publisher page 28 citations
Abstract
Many pediatric psoriasis patients suffer from nail involvement and psoriatic arthritis. In adults, biologic agents have demonstrated success in treating refractory nail psoriasis and arthritis, but studies are limited in children. In this report, we present a pediatric patient with severe, recalcitrant nail and joint psoriasis, successfully treated with secukinumab.